MiNK Therapeutics

INKTNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$50.724 M

$9.94 -7.71%

Close of 6 Nov 2026

As of 6 Nov 2026, MiNK Therapeutics (INKT) has a market capitalization of $50.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$12.5M

Loss-making

Shares outstanding

5,103,002

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#122Kalaris TherapeuticsKLRS$55.9M
#123Eloxx PharmaceuticalsELOX$52.1M
#124MiNK TherapeuticsINKT$50.7M
#125Greenland MinesGRML$49.3M
#126Instil BioTIL$47.9M

What if MiNK Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$5,533,385

Per share 556,679× higher

Bitcoin $1.53T

$299,401.82

Per share 30,121× higher

Apple $5.02T

$982,908.22

Per share 98,884× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for MiNK Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.